NK Cells in the Lymph Nodes and Their Role in Anti-Tumour Immunity de réir Lara V. Graham, Salim I. Khakoo, Matthew D. Blunt

Faigh an téacs iomlán

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer de réir Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, Salim I. Khakoo, Matthew D. Blunt

Faigh an téacs iomlán

Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E de réir Jack G. Fisher, Christopher J. Walker, Amber DP. Doyle, Peter WM. Johnson, Francesco Forconi, Mark S. Cragg, Yosef Landesman, Salim. I. Khakoo, Matthew D. Blunt

Faigh an téacs iomlán

Constitutive Activation of Natural Killer Cells in Primary Biliary Cholangitis de réir Theresa J. Hydes, Matthew D. Blunt, Jennifer Naftel, Andres F. Vallejo, Grégory Seumois, Alice Wang, Pandurangan Vijayanand, Pandurangan Vijayanand, Marta E. Polak, Salim I. Khakoo

Faigh an téacs iomlán

Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors de réir Aymen Al-Shamkhani, Marta E Polak, Pauline Rettman, Matthew D Blunt, Rebecca J Fulton, Andres F Vallejo, Leidy Y Bastidas-Legarda, Laura España-Serrano, Christelle Retiere, Salim I Khakoo

Faigh an téacs iomlán

KIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies de réir Lara V. Graham, Jack G. Fisher, Amber D. P. Doyle, Ben Sale, Luis Del Rio, Albert J. E. French, Neema P. Mayor, Neema P. Mayor, Thomas R. Turner, Thomas R. Turner, Steven G. E. Marsh, Steven G. E. Marsh, Mark S. Cragg, Mark S. Cragg, Francesco Forconi, Francesco Forconi, Salim I. Khakoo, Matthew D. Blunt

Faigh an téacs iomlán